Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Other Operating Expenses (2021 - 2025)

Biomerica's Other Operating Expenses history spans 11 years, with the latest figure at $462000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $462000.0; the TTM value through Nov 2025 reached -$465000.0, down 46600.0%, while the annual FY2021 figure was $461.0, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2025 was $462000.0 at Biomerica, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $462000.0 in Q4 2025 and bottomed at -$3.8 million in Q2 2021.
  • The 5-year median for Other Operating Expenses is $67.0 (2022), against an average of -$355177.6.
  • The largest annual shift saw Other Operating Expenses skyrocketed 5505.41% in 2023 before it plummeted 200.0% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $70522.0 in 2021, then plummeted by 100.05% to -$37.0 in 2022, then skyrocketed by 5505.41% to $2000.0 in 2023, then crashed by 50.0% to $1000.0 in 2024, then soared by 46100.0% to $462000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Other Operating Expenses are $462000.0 (Q4 2025), -$1000.0 (Q2 2025), and -$926000.0 (Q1 2025).